It was found that in endometrial cancer, circRAPGEF5 acts with RNA binding fox-1 homolog 2 (RBFOX2) to block the binding of RBFOX2 to pre-mRNA and inhibit TFRC expression. Here, RBFOX2 is linked to endometrial cancer.